These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25349530)

  • 1. Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.
    Ingram DR; Dillon LM; Lev DC; Lazar A; Demicco EG; Eisenberg BL; Miller TW
    BMC Clin Pathol; 2014; 14():42. PubMed ID: 25349530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    J Urol; 2004 Feb; 171(2 Pt 1):611-4. PubMed ID: 14713771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
    Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
    BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.
    Micello D; Marando A; Sahnane N; Riva C; Capella C; Sessa F
    Virchows Arch; 2010 Oct; 457(4):467-76. PubMed ID: 20809337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
    Kensler KH; Regan MM; Heng YJ; Baker GM; Pyle ME; Schnitt SJ; Hazra A; Kammler R; Thürlimann B; Colleoni M; Viale G; Brown M; Tamimi RM
    Breast Cancer Res; 2019 Feb; 21(1):30. PubMed ID: 30795773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.
    Qi JP; Yang YL; Zhu H; Wang J; Jia Y; Liu N; Song YJ; Zan LK; Zhang X; Zhou M; Gu YH; Liu T; Hicks DG; Tang P
    Breast Cancer (Auckl); 2012; 6():1-8. PubMed ID: 22259247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
    Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW; Lee KS
    Ann Oncol; 2011 Aug; 22(8):1755-62. PubMed ID: 21310761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
    García X; Elía A; Galizzi L; May M; Spengler E; Martínez Vázquez P; Burruchaga J; Gass H; Lanari C; Lamb CA
    Breast Cancer Res Treat; 2020 Feb; 180(1):257-263. PubMed ID: 31950383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
    Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
    Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.
    Agoff SN; Swanson PE; Linden H; Hawes SE; Lawton TJ
    Am J Clin Pathol; 2003 Nov; 120(5):725-31. PubMed ID: 14608899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer.
    Prabhu JS; Korlimarla A; Rajarajan S; Alexander A; Anupama C; Ramesh R; Srinath B; Sridhar TS
    Cancer Res; 2021 Feb; 81(4 Suppl):. PubMed ID: 34421401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women.
    Proctor E; Kidwell KM; Jiagge E; Bensenhaver J; Awuah B; Gyan K; Toy K; Oppong JK; Kyei I; Aitpillah F; Osei-Bonsu E; Adjei E; Ohene-Yeboah M; Brewer RN; Fondjo LA; Owusu-Afriyie O; Wicha M; Merajver S; Kleer C; Newman L
    Ann Surg Oncol; 2015 Nov; 22(12):3831-5. PubMed ID: 25743329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.
    Can NT; Lingen MW; Mashek H; McElherne J; Briese R; Fitzpatrick C; van Zante A; Cipriani NA
    Head Neck Pathol; 2018 Mar; 12(1):95-104. PubMed ID: 28681314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
    Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
    Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Cancer; 2012 Jan; 118(1):157-63. PubMed ID: 21713768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
    Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case-control study.
    Mashhadi R; Pourmand G; Kosari F; Mehrsai A; Salem S; Pourmand MR; Alatab S; Khonsari M; Heydari F; Beladi L; Alizadeh F
    Urol J; 2014 Nov; 11(6):1968-73. PubMed ID: 25433476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.